FASLG and colorectal carcinoma: As shown in Fig 5C, expression levels of FASLG and TNFRSF11B could be used to stratify patients by K-means clustering into two subgroups (low- and high-risk groups) which exhibited significant differences (p<0.001) in CRC-specific survival according to a Kaplan-Meier survival analysis (Fig 5D).